TickerFacts.

RenovoRx, Inc. (RNXT): Gross Profit

Annual figures by period end, from SEC filings.

$796.0K
Year ended 2025-12-31
$1.67M
Trailing 12 months to 2026-06-30
2024-12-31: $43.0K2025-12-31: $796.0K$796.0K
2024-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$796.0Kn/m2026-03-30, From 2025-01-01
2024-12-31$43.0Kn/a2026-03-30, From 2024-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
RenovoRx, Inc. (RNXT)2025-12-31$796.0Kn/m
PetVivo Holdings, Inc. (PETV)2026-03-31$754.8K-24.1%
SeaStar Medical Holding Corp (ICU)2025-12-31$1.18M+774.8%
Sintx Technologies, Inc. (SINT)2025-12-31$461.0K-77.8%
Catheter Precision, Inc. (VTAK)2025-12-31$756.0K+100.0%
EBR Systems, Inc. (NONE.)2025-12-31$490.0Kn/a
Vycor Medical Inc (VYCO)2025-12-31$1.56M+9.7%
Co-Diagnostics, Inc. (CODX)2025-12-31$400.1K-86.3%
Femasys Inc (FEMY)2025-12-31$1.42M+31.1%

Compare RNXT, PETV, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗